INVA
INVA
NASDAQ · Pharmaceuticals

Innoviva Inc

$20.57
-0.54 (-2.56%)
As of Aug 8, 1:39 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 1 9%
Sell 1 9%
Price Target
Analyst Price Target +90.4% upside
Low Target $23.99
Average Target $39.16
High Target $41.33
Current Price $20.57
Current
$20.57
Target
$39.16
$23.99 $39.16 avg $41.33
Scenario Analysis
Bear Case
$23.99
16.6%
Low target
Base Case
$39.16
+90.4%
Avg target
Bull Case
$41.33
+100.9%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$25.15
-18.2% from high
52-Week Low
$16.52
+24.5% from low
Target vs 52W High
$39.16
+55.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%